Text Size

Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

This study is currently recruiting participants.
Verified February 2013 by National Institutes of Health Clinical Center (CC)
Sponsor:
Information provided by:
National Institutes of Health Clinical Center (CC)
ClinicalTrials.gov Identifier:
NCT00026689
First received: November 14, 2001
Last updated: April 12, 2013
Last verified: February 2013
History of Changes
  Purpose

Background:

-This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols.

Objectives:

-To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.

Eligibility:

-Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.

Design:

-This is a screening protocol. No investigational treatments will be administered on this protocol.


Condition
Neoplasm

Study Type: Observational
Official Title: Evaluation for NCI Radiation Oncology Branch Clinical Research Protocols

Resource links provided by NLM:

MedlinePlus related topics: Cancer
U.S. FDA Resources

Further study details as provided by National Institutes of Health Clinical Center (CC):

Estimated Enrollment: 1000
Study Start Date: July 2000
Detailed Description:

Background:

-This protocol will provide a means for screening potential candidates for NCI Radiation Oncology Branch (ROB) protocols.

Objectives:

-To permit evaluation of patients referred to the NCI Radiation Oncology Branch in order to identify individuals who will be suitable candidates for Radiation Oncology Branch clinical research protocols.

Eligibility:

-Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.

Design:

-This is a screening protocol. No investigational treatments will be administered on this protocol.

  Eligibility

Ages Eligible for Study:   4 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria
  • INCLUSION CRITERIA:

Patients suspected of having, or with biopsy proven malignant disease or patients with a benign condition for whom radiotherapy is a potential treatment.

Patient or guardian is able to provide informed consent.

EXCLUSION CRITERIA:

Candidates who do not meet the inclusion criteria.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00026689

Contacts
Contact: Sharon L Smith, R.N. (301) 451-8905 smiths@mail.nih.gov
Contact: Kevin A Camphausen, M.D. (301) 496-5457 camphauk@mail.nih.gov

Locations
United States, Maryland
National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting
Bethesda, Maryland, United States, 20892
Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office     (888) NCI-1937        
Sponsors and Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Kevin A Camphausen, M.D. National Cancer Institute (NCI)
  More Information

Additional Information:
NIH Clinical Center Detailed Web Page  This link exits the ClinicalTrials.gov site

No publications provided

ClinicalTrials.gov Identifier: NCT00026689     History of Changes
Obsolete Identifiers: NCT00020280
Other Study ID Numbers: 000181, 00-C-0181
Study First Received: November 14, 2001
Last Updated: April 12, 2013
Health Authority: United States: Federal Government

Keywords provided by National Institutes of Health Clinical Center (CC):
Screening
Cancer

Additional relevant MeSH terms:
Neoplasms

ClinicalTrials.gov processed this record on June 18, 2013